Jane Tighe
Impact in
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
Papers in
- Hematology 10
- Acute Myeloid Leukemia Research 4
- Multiple Myeloma Research and Treatments 4
- Oncology 8
- Peptidase Inhibition and Analysis 3
- Co-authors
- Chris Fegan (3 shared papers)Saad M. B. Rassam (2 shared papers)Ben Kennedy (2 shared papers)Andrew Haynes (2 shared papers)Andy C. Rawstron (2 shared papers)M.J. Leach (2 shared papers)Paul Moreton (2 shared papers)David Oscier (2 shared papers)
- Journals
- Blood (3 papers)British Journal of Haematology (3 papers)Journal of Clinical Oncology (1 paper)Cell Cycle (1 paper)BMC Medical Education (1 paper)
- Partner nations
- United KingdomUnited StatesDenmark
In The Last Decade
Jane Tighe
18 papers receiving 773 citations
Peers
Comparison fields: 5 of 71
- Genetics 367
- Hematology 255
- Pathology and Forensic Medicine 379
- Immunology 209
- Oncology 194
Countries citing papers authored by Jane Tighe
This map shows the geographic impact of Jane Tighe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Tighe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Tighe more than expected).
Fields of papers citing papers by Jane Tighe
This network shows the impact of papers produced by Jane Tighe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Tighe. The network helps show where Jane Tighe may publish in the future.
Co-authors
The 25 scholars most cited alongside Jane Tighe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 293 | |
| 2 | 2004 | 222 | |
| 3 | 2010 | 84 | |
| 4 | 2007 | 64 | |
| 5 | 2007 | 39 | |
| 6 | 2003 | 19 | |
| 7 | 2003 | 15 | |
| 8 | 1995 | 14 | |
| 9 | 2011 | 6 | |
| 10 | 2007 | 5 | |
| 11 | 2000 | 5 | |
| 12 | A pilot study of CODOX-M/IVAC in primary refractory or relapsed high-grade non-Hodgkin's lymphoma. A Scotland and Newcastle Lymphoma Group Study. | 2003 | 5 |
| 13 | 2014 | 4 | |
| 14 | 2020 | 4 | |
| 15 | 2022 | 3 | |
| 16 | 2007 | 2 | |
| 17 | 2000 | 1 | |
| 18 | 2018 | 1 | |
| 19 | 2024 | 0 |
About Jane Tighe
Jane Tighe is a scholar working on Hematology, Oncology, Genetics, Pathology and Forensic Medicine and Molecular Biology, having authored 19 papers that have together received 786 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), Acute Myeloid Leukemia Research (4 papers), Multiple Myeloma Research and Treatments (4 papers), Peptidase Inhibition and Analysis (3 papers), Protein Degradation and Inhibitors (2 papers), Protease and Inhibitor Mechanisms (2 papers) and Blood properties and coagulation (2 papers). The work is most often cited by research in Genetics (367 citations), Hematology (255 citations), Pathology and Forensic Medicine (379 citations), Immunology (209 citations) and Oncology (194 citations). Jane Tighe has collaborated with scholars based in United Kingdom, United States and Denmark. Frequent co-authors include Chris Fegan, Saad M. B. Rassam, Ben Kennedy, Andrew Haynes, Andy C. Rawstron, M.J. Leach, Paul Moreton, David Oscier, Peter Hillmen and Guy Lucas. Their work appears in journals such as Blood, British Journal of Haematology, Journal of Clinical Oncology, Cell Cycle and BMC Medical Education.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.